The drugmaker says its mRNA vaccine worked in 90% of patients in its trial, but some observers question how long immunity will last and who will benefit.
from WebMD Health https://www.webmd.com/lung/news/20201111/five-important-questions-about-pfizers-covid-19-vaccine?src=RSS_PUBLIC
0 Comments:
Post a Comment